Forward P/S Multiple: SANUWAVE (SNWV)

Sanuwave Health Inc - graphic logo of issuer SNWV

Sanuwave Health Inc (SNWV) is implementing acoustic systems for the healing of diabetic ulcers, leveraging new insurance codes. The expert team is driven by stock options and innovations in regeneration. The strategy is based on expanding B2B sales within US clinics. The expected P/S multiple confirms these trends, while 0.40 reflects the baseline level of the metric, helping to assess market value relative to revenue.

sanuwave.com - SNWV Market Cap to Projected Revenue (period 03/08/2025 - 11/15/2026)

Summary analytical data breakdowns for Sanuwave Health Inc (SNWV)

- market price and analyst price targets:
- company stock exchange capitalization indicators:
Fundamental company analysis:SNWV (SANUWAVE Health, Inc.)
Product sample of SANUWAVE Health Inc

Sanuwave Health Inc (SNWV) innovations in tissue regeneration and its strategic focus on highly qualified personnel drive the potential for future revenues. By analyzing the forward P/S dynamics, an investor can observe the ratio of current market capitalization to expected sales, which allows for an assessment of the fundamental margin of safety and the filtering out of market noise to determine whether the business valuation is justified by upcoming growth or remains susceptible to recession risks.

Who Sanuwave Health Inc competes with

Price-to-Projected Revenue Ratio Dexcom CGM DXCM|Penumbra Corp (PEN) - Market Cap to Future Revenue Ratio|Novanta Inc - Forward P/S Multiple|HAE (Haemonetics Corporation) - Market Cap to Projected Revenue|INSP: Forward P/S Multiple|Market Cap to Projected Revenue PRCT|CNMD (CONMED Inc.) - Forward P/S Multiple|Pulse Corp (PLSE) - Market Cap to Expected Sales Ratio|Forward P/S Multiple INMD|Forward P/S Multiple picardmedical.com (PMI)|Forward P/S Multiple SRDX (surmodics.com)|Forward P/S Multiple Senseonics Holdings, Inc. SENS|NPCE - Price-to-Projected Revenue Ratio|TCMD: Price-to-Projected Revenue Ratio|Outset Medical Corp (OM) - Price-to-Projected Revenue Ratio|SmartVest - Forward Price to Sales|LNSR (LENSAR Inc) - Forward P/S Multiple|Market Cap to Future Revenue Ratio AVITA Medical Inc. RCEL|Price-to-Projected Revenue Ratio Profound Medical (PROF)|Baird Medical Corp (BDMD) - Projected Price to Revenue|EDAP TMS SA - Forward Price-to-Revenue Multiple|Forward P/S Multiple Bovie Medical APYX|IceCure Medical Ltd. - Forward P/S Multiple|Market Cap to Expected Sales Ratio Pulmonx LUNG|TELA Bio (TELA) - Price-to-Projected Revenue Ratio|Future Price to Revenue CTSO (CytoSorbents Corp.)|Price-to-Projected Revenue Ratio sensushealthcare.com|Forward Price-to-Revenue Multiple Zynex, Inc. (ZYXI)|Forward P/S Multiple ECOR|RBOT - Market Cap to Future Revenue Ratio|Price-to-Projected Revenue Ratio inspira-technologies.com IINN|Price to Expected Revenue Ratio ICU (SeaStar Medical Holding Corp.)|IRIX: Forward Price-to-Revenue Multiple|ibs.inc - Price to Expected Revenue Ratio|XAIR: Forward P/S Multiple|Future Price to Revenue PFSA (Profusa Inc.)|Forward Price-to-Revenue Multiple SSKN|Price-to-Projected Revenue Ratio GCTK|Price-to-Projected Revenue Ratio NanoVibronix (NAOV)|Venus Concept - Market Cap to Projected Revenue|Forward P/S Multiple NUWE (Nuwellis Corp)|Forward Price to Sales AEMD|ASXC - Price-to-Projected Revenue Ratio|Projected Price to Revenue Avinger, Inc (AVGR)|BSGM: Forward P/S Multiple|Cutera (CUTR) - Forward P/S Multiple|KNW (Know Labs) - Forward P/S Multiple|Forward Price-to-Revenue Multiple Inari Medical (NARI)|Price-to-Projected Revenue Ratio nevro.com (NVRO)|RSLS (ReShape Lifesciences, Inc.) - Forward Price to Sales|Forward P/S Multiple SILK (Silk Road Medical)